Abstract: To validate optical coherence tomography (OCT) for the diagnosis of referable retinopathy (severe, very severe or proliferative retinopathy, and macular edema) in diabetic patients.
INTRODUCTION

D
iabetic retinopathy is the leading cause of blindness in the population under 75 years of age in developed countries, and diabetic macular edema is the leading cause of vision loss. 1, 2 Recent decades have seen the development of strategies for diabetic retinopathy screening, such as the nonmydriatic fundus camera, though this has limitations for diagnosing diabetic macular edema. [3] [4] [5] [6] [7] [8] [9] [10] Retinal cameras capable of taking stereoscopic images have also been developed, but they require skilled technicians and a more costly infrastructure. 11, 12 A recently developed device, optical coherence tomography (OCT), provides quantitative evaluation rather than the qualitative assessment performed by macular biomicroscopy or fundus photography. [13] [14] [15] [16] OCT is also available with an incorporated retinal camera that enables both tests to be conducted with a single image capture.
Others have demonstrated the validity of OCT as a diagnostic method for macular edema in diabetic patients. However, these studies have not determined the validity of OCT to detect referable retinopathy (preproliferative, proliferative, and macular edema). We therefore conducted a study in a Spanish region assessing the validity of OCT, concurrently employing the quantitative value of OCT, fundus photography, and presence of retinal cysts. The aim of this study was to validate OCT as a method to accurately identify referable retinopathy.
METHODS
Study Population
The study population consisted of diabetic patients able to be seen at the outpatient ophthalmology department of the General University Hospital of Elche (Spain). This hospital provides free health coverage to a total of 169,555 inhabitants.
Design and Participants
This was an observational, cross-sectional study to determine the validity of a diagnostic test. A random sample was analyzed of patients diagnosed with diabetes mellitus (ICD-9-CM 250.X) referred to the general university hospital of Elche to be studied in compliance with the referral protocol (when the patient reports sudden loss of visual acuity, is suspected of having proliferative retinopathy, advanced retinopathy is shown on nonmydriatic retinography screening or there is evidence of cataracts) for diabetic patients in the period between October 2012 and June 2013. The sampling procedure consisted of determining a random day each week (not always the same day) and recruiting patients who came that day and chose to participate in the study, through linear systematic sampling. We excluded all patients who met any of the following criteria: dementia, cataract surgery in the last 3 months, laser treatment in the macular region or panphotocoagulation, antiangiogenic drugs, vitreoretinal surgery, high myopia, or other macular disorders.
Variables and Measures
The primary variable (gold standard) was referable retinopathy (preproliferative, proliferative, and macular edema) measured by clinical ophthalmological examination of the retina with indirect ophthalmoscopy and biomicroscopy of the central retina with a Topcon SL-8Z Slit Lamp (Topcon Corporation, Tokyo, Japan) through a 78 diopter lens (78D aspherical lens, Volk Optical Incorporated, Mentor, OH) and a 28D lens indirect ophthalmoscope. Macular edema was defined as the presence of hard exudates or retinal thickening located within a distance of 500 mm of the fovea, and the degree of diabetic retinopathy was defined according to the Early Treatment Diabetic Retinopathy Study (ETDRS) study classification. 17 These assessments were performed by an ophthalmologist experienced in retinal disorders.
Three parameters were acquired from the OCT (Topcon 3D OCT-2000, Topcon Corporation 1 ), which were interpreted by a different ophthalmologist and in a masked fashion with respect to the other screening tests. These parameters were: determination of central foveal thickness, the presence of intraretinal fluid, and fundus photographs.
To determine the foveal thickness, images were generated using 512 horizontal and 128 vertical scan lines comprised of 512 A-scans, applying the 6 Â 6 mm 3D cube protocol centered on the fixation point after dilating the pupil with 10 mg/mL tropicamide. The mean retinal thickness was automatically calculated by the instrument software. For the measurement we used a 6 mm diameter area, the center of which coincided with the fovea, and this was used for evaluating the central 1000 mm area (the central circle).
The system performed a horizontal optical tomography image of the retina (B-Scan), which assessed the existence of intraretinal fluid (cysts or intraretinal spaces).
Fundus images taken by OCT included the macular region up to the nasal border of the optic nerve head at 458, assessing diabetic retinopathy according to the classification established by the ETDRS. Preproliferative, proliferative, or nonassessable retinopathy was considered an abnormal finding. OCT takes a measurement of the 3 parameters at the same time, displaying results on a single screen (Figure 1) . Finally, at a descriptive level, the study recorded: age (years), diabetes evolution (years), HbA1c (%), fasting blood glucose (mmol/L), best corrected visual acuity, gender, type of diabetes mellitus, dyslipidemia, hypertension, and smoking status. These parameters were collected through the clinical history and patient interview, except corrected visual acuity, which was measured by the Snellen test.
Sample Size
The total sample size was 136 eyes, 48 of which had diabetic retinopathy or macular edema. To test for a Kappa statistic different from 0.4 and assuming a 95% confidence interval (CI), 35% agreement, and a Kappa coefficient of 0.8, the power of the test was 99.83%. 18 The value of 0.4 was chosen because it represents moderate agreement. 
Statistical Methods
Qualitative variables were described by calculating absolute and relative frequencies, while quantitative variables were described by means and standard deviations.
The receiver operating characteristic (ROC) curve was calculated using macular edema as the status variable and foveal thickness as the continuous variable. The minimum thickness with a positive likelihood ratio strictly >10 was determined. This value was chosen because it provided type A evidence in the confirmation of a diagnostic test. 20, 21 To determine the validity of OCT the following diagnostic test was defined: Positive: if the patient met at least 1 of these criteria: foveal thickness greater than the point obtained from the ROC curve defined previously, intraretinal fluid, an abnormal fundus image; Negative: If none of the above criteria was met.
Sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios, and the Kappa statistic were determined.
All analyses were conducted at a 5% significance level and for each relevant parameter its associated CI was calculated. The statistical package used was SPSS Statistics 19.0.
Ethical Issues
The study did not provide any additional risk to the patient. The study was conducted according to the principles of the World Medical Association Declaration of Helsinki and met the standards described in the European Union guidelines for good clinical practice. The patients were informed orally about the study and of the necessary information they had to provide. This study and the use of oral consent were approved by the Ethics Committee of the University General Hospital of Elche.
RESULTS
Of the initial 142 eyes of the diabetic patients included in our sample, 2 were excluded because they had epiretinal membrane, 2 due to vitreomacular traction syndrome, and 2 due to age-related macular degeneration. This left a final sample of 136 eyes, of which 48 had referable retinopathy (35.3%; 95% CI: 27.3-43.3) (12 with macular edema only, 6 with retinopathy only, and 30 with both conditions). Table 1 shows the descriptive information of the sample. Regarding OCT parameters, the mean foveal thickness was 268.6 mm, 36 eyes (26.5%) showed the presence of intraretinal fluid, and 28 had an abnormal fundus photograph (20.6%). With respect to the remaining descriptive features, we note that there was a higher proportion of type 2 diabetes (80.9%) and an elevated mean HbA1c (7.7%).
The area under the ROC curve (AUC) for central foveal thickness was 0.89 (95% CI: 0.81-0.97, P < 0.001) and its lowest value with a positive likelihood ratio >10 was 275 mm (Figure 2) .
The diagnostic test constructed was positive in 50 eyes (44 with referable retinopathy) and negative in 86 (82 without referable retinopathy). This produced the following parameters for the diagnostic test: sensitivity, 91.67% (95% CI: 79.13-97.30); specificity, 93.18% (95% CI: 85.19-97.20); positive predictive value, 88.00% (95% CI: 75.00-95.03); negative predictive value, 95.35% (95% CI: 87.87-98.50); positive likelihood ratio, 13.44% (95% CI: 6.18-29.24); and negative likelihood ratio, 0.09% (95% CI: 0.03-0.23). The kappa statistic was 0.84% (95% CI: 0.75-0.94, P < 0.001).
DISCUSSION
Our study evaluated the validity of OCT as a screening method while also assessing the 3 parameters it determined: central foveal thickness, fundus photography, and the presence of intraretinal fluid. In this validation, very relevant clinical parameters were obtained, since the likelihood ratios had type A evidence, both to confirm and to rule out the diagnosis of referable retinopathy. 20, 21 Furthermore, once the role of chance (Kappa index) was removed, correlation with the gold standard It was difficult to compare our results with those of others because we found no studies analyzing the validity of OCT while at the same time taking into account the 3 parameters used in our paper and detecting both retinopathy and macular edema in the diabetic patient. In the meta-analysis by Virgili et al, the validity of the foveal thickness measured with OCT was evaluated to detect diabetic macular edema and a pooled sensitivity of 78% and a specificity of 86% (likelihood ratio: positive, 5.57; negative, 0.26) were determined. 22 In another meta-analysis, by Bragge et al, the pooled sensitivity and specificity of diagnostic tests were calculated to detect diabetic retinopathy with mydriasis. 23 Sensitivity was 84.5% and specificity was 88.6% (likelihood ratio: positive, 7.41; negative, 0.17).
The results of this paper show that by using all the components of OCT, a diagnostic test with type A evidence is obtained that can be used to diagnose referable retinopathy. If a patient is referred to the ophthalmology department with suspected referable retinopathy, it would be advisable to perform the diagnostic test constructed herein. In the case of a negative result, the patient would be referred to their primary care physician to be followed as per protocol. On the other hand, if the test is positive, the patient would be reviewed and treated at the ophthalmology department.
Strengths and Limitations of the Study
The main strength of this study is that it innovatively constructed a diagnostic test with type A evidence able to diagnose referable retinopathy in patients who had already been referred to the ophthalmology department for suspected diabetic retinopathy. Moreover, once the role of chance was eliminated, the correlation between the gold standard and our diagnostic test was 0.84, representing excellent agreement. 24 In addition, the statistical power to compare the value of this index with 0.4 (moderate agreement) was close to 100%.
Concerning limitations, we note that the patients analyzed already had suspected diabetic retinopathy; therefore, studies to determine the validity of OCT, using its 3 components, in the general diabetic population would be of interest. To minimize selection bias, a random sample of patients was selected from the study population analyzed. Finally, regarding information bias, calibrated instruments were used by expert ophthalmologists.
CONCLUSION
This study contributes a diagnostic test for referable diabetic retinopathy based on the 3 components of OCT, with type A evidence, to confirm or rule out the disease. However, these results have been obtained in a referred population. Consequently, studies are needed to determine the validity of this test in the general diabetic population.
